Big news in the world of medicine! An Indian company, Sun Pharma, is buying a U.S. company called Checkpoint Therapeutics. Checkpoint makes a special medicine called Unloxcyt that helps fight cancer.
This is a big deal because Unloxcyt is the first of its kind approved to treat a specific type of skin cancer. Sun Pharma is paying a lot of money for Checkpoint.
- Sun Pharma will pay $4.10 per share for Checkpoint.
- Checkpoint’s stock price jumped up a lot after the news.
- The deal should be finished in the second part of 2025.
| Item | Information |
|---|---|
| Price per share | $4.10 |
| Stock price increase | 64.2% |
| Deal Completion | Second Quarter 2025 |
